EVOLVENCT07378514
Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic Devices
At risk: Enrollment reduced 60%.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrollment reduced: 30000 → 12000 participants Show 8 more changesShow less
- Recruitment opened
- Primary completion moved earlier from Apr 2031 to Apr 2028
- Start date changed from estimate of Apr 2026 to Aug 24, 2026
- Eligibility criteria expanded, about 16 words
- Study completion moved earlier from Jul 2031 to Jul 2028
- Study sites: 0 to 1
- Study description expanded, about 167 words
- Study title shortened, about 4 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Arms and interventions
participants presenting with symptoms indicative of thromboembolic events
participants presenting with symptoms indicative of infection or inflammatory disorders
participants presenting with symptoms indicative of heart failure or acute coronary syndrome
participants presenting with symptoms indicative of renal disorders
participants with ongoing vitamin K antagonist therapy for at least four weeks
participants with suspected pre-Diabetes or diagnosed with Diabetes Mellitus Type 1 or Type 2
participants presenting with symptoms indicative of Hypercholesterolemia
participants with symptoms indicative of hepatic disorders
Diagnostic tests: Blood samples are obtained and pseudonymized, prior to use for the development, optimization and calibration of diagnostic tests
Sites
1 site in 1 country
- Golden Jubilee National HospitalGlasgow, United Kingdom